Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05283564

Study to Evaluate Percussive Ventilation Breathhold to Improve Lung Stereotactic Ablative Radiotherapy

A Pilot Study to Evaluate Percussive Ventilation Breathhold to Improve Lung Stereotactic Ablative Radiotherapy (PVB-SABR)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this research is to evaluate and determine the rate of successful administration of Percussive ventilation breathhold (PVB) to allow for more accurate radiotherapy for lung tumors.

Detailed description

Primary Objective(s) * To determine the rate of successful administration of the PVB-SABR in lung cancer patients. * To determine the rate of successful administration of PVB in healthy volunteers for 5 minutes Secondary Objective(s) * To determine the rate of successful administration of PVB in healthy volunteers for 10 minutes as well as for patients' successfully completing the technique for 5 and 10 minutes. * To collect exploratory clinical (both arms) and dosimetric data from lung cancer patients using PVB-SABR.

Conditions

Interventions

TypeNameDescription
OTHERPercussive Ventilation Breathhold SABR (PVB-SABR)Number of lung cancer patients with successful administration of PVB technique in PVB-SABR treatment

Timeline

Start date
2022-11-02
Primary completion
2026-05-04
Completion
2026-09-04
First posted
2022-03-17
Last updated
2025-07-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05283564. Inclusion in this directory is not an endorsement.